Exagen’s (XGN) “Outperform” Rating Reiterated at William Blair
William Blair reiterated their outperform rating on shares of Exagen (NASDAQ:XGN – Free Report) in a research note released on Wednesday,RTT News reports. William Blair also issued estimates for Exagen’s Q1 2025 earnings at ($0.20) EPS, Q2 2025 earnings at ($0.16) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at ($0.07) EPS, FY2025 […]
William Blair reiterated their outperform rating on shares of Exagen (NASDAQ:XGN – Free Report) in a research note released on Wednesday,RTT News reports. William Blair also issued estimates for Exagen’s Q1 2025 earnings at ($0.20) EPS, Q2 2025 earnings at ($0.16) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at ($0.07) EPS, FY2025 […]
